Overview
Munich, 5 August 2025 – McDermott Will & Schulte, with a team led by Holger Ebersberger and Thomas Diekmann, advised NORD Holding and its portfolio company 1Q Health Group on the acquisition of Beauty Production GmbH, a specialist in the manufacture of liquid dietary supplements and cosmetics.
The acquisition expands 1Q Health Group’s capabilities in the liquid segment and underscores its expertise in the development and production of innovative and high-growth dosage forms.
Located near Bayreuth, Germany, Beauty Production covers the entire value chain from development and private label programs to manufacturing and filling.
1Q Health is a leading European CDMO and development partner for dietary supplements and pharmaceuticals. The company produces hard capsules, liquids, powders, and tablets under GMP and IFS/FSSC conditions at three production sites in Germany and Austria.
NORD Holding is a private equity and asset management company with approximately €4 billion in assets under management. Through its direct investment arm, NORD Holding currently holds stakes in 14 companies in the DACH region.
McDermott advised NORD Holding on various transactions and add-on transactions, including the acquisition of ABJ alive and HKS as the cornerstone of the formation of 1Q Health Group.
The McDermott team was led by partner Holger H. Ebersberger and counsel Thomas Diekmann and included associates Parsin Walsi and Athanasia Eleftheriadou.
About Us
Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.
